Rheumatology treats musculoskeletal and autoimmune diseases, including arthritis, lupus, gout, and vasculitis.
Send us all your questions or requests, and our expert team will assist you.
Accurate diagnosis and evaluation of polymyalgia rheumatica (PMR) is essential for initiating timely therapy and preventing complications. This page is designed for international patients and their caregivers who seek a clear understanding of how clinicians identify and monitor this inflammatory condition. Approximately 10 % of individuals over 65 develop PMR, and early recognition can reduce pain, stiffness, and the need for prolonged high‑dose steroids. Below, we outline the step‑by‑step approach used by the rheumatology team at Liv Hospital, from the first clinical impression to long‑term follow‑up.
Our comprehensive overview combines clinical expertise with evidence‑based protocols, ensuring that patients receive a personalized assessment aligned with international standards. Whether you are preparing for a consultation or reviewing your treatment plan, the information presented here will help you navigate the diagnostic pathway with confidence.
The first pillar of diagnosis and evaluation lies in a thorough history and physical examination. Polymyalgia rheumatica typically presents with abrupt onset of bilateral shoulder and pelvic girdle pain, accompanied by morning stiffness lasting more than 45 minutes. Key clinical features include:
During the physical exam, physicians assess range of motion, palpate tender areas, and check for associated conditions like giant cell arteritis. The assessment also records comorbidities that may influence treatment choices, such as diabetes or osteoporosis.
Documenting the timeline of symptom development is crucial. Patients often report that symptoms began within the past two weeks, a pattern that helps differentiate PMR from other rheumatic diseases that evolve more slowly.
Symptoms are usually symmetrical and may include:
Physical findings often reveal:
Laboratory investigations provide objective evidence of inflammation and help rule out mimicking disorders. The most informative markers in the diagnosis and evaluation of PMR are:
While these tests are not disease‑specific, their combined pattern supports the clinical suspicion of PMR. In rare cases, additional serologic studies (e.g., rheumatoid factor, anti‑CCP) are ordered to exclude rheumatoid arthritis.
Repeated testing after initiating therapy helps confirm the diagnosis; a rapid decline in ESR and CRP within 2–4 weeks is characteristic of PMR.
Imaging is not mandatory for the primary diagnosis and evaluation of polymyalgia rheumatica, but it plays a valuable role when the clinical picture is ambiguous or when clinicians need to exclude alternative pathologies.
Below is a comparison of imaging modalities frequently employed in the work‑up of PMR:
When imaging confirms peri‑articular inflammation without erosive changes, it reinforces the clinical diagnosis and guides the rheumatology team at Liv Hospital in tailoring treatment.
Polymyalgia rheumatica shares several features with other rheumatic and musculoskeletal disorders. A systematic differential diagnosis ensures that patients receive the most appropriate therapy.
The table below highlights key distinguishing features:
By systematically ruling out these alternatives, the rheumatology specialists at Liv Hospital can confidently confirm PMR and avoid unnecessary immunosuppression.
After establishing the diagnosis, ongoing evaluation focuses on treatment response, steroid tapering, and detection of complications. The standard follow‑up schedule includes:
During each visit, clinicians reassess pain scores, morning stiffness duration, and functional ability using validated tools such as the Health Assessment Questionnaire (HAQ). Laboratory monitoring repeats ESR and CRP to ensure inflammatory markers remain within normal limits.
Potential adverse effects of long‑term corticosteroids are proactively managed. Liv Hospital offers integrated services—including endocrinology consultation, physiotherapy, and nutrition counseling—to mitigate risks such as hyperglycemia, hypertension, and bone loss.
Patients who experience a relapse (return of symptoms or rise in inflammatory markers) may require a temporary increase in steroid dosage or the addition of steroid‑sparing agents like methotrexate. The personalized care pathway ensures that each individual receives the minimal effective dose while maintaining quality of life.
Liv Hospital combines JCI accreditation, a multilingual care team, and state‑of‑the‑art facilities to deliver world‑class rheumatology services to international patients. Our specialists follow evidence‑based protocols, provide coordinated logistics—from airport transfer to interpreter support—and tailor each treatment plan to the unique needs of patients traveling from abroad.
Ready to schedule your comprehensive evaluation for polymyalgia rheumatica? Contact Liv Hospital today to arrange a personalized appointment and experience seamless, expert care from the moment you arrive.
Liv Hospital Ulus
Spec. MD. Yıldız Gonca Doğru
Physiotheraphy and Rehabilitation
Liv Hospital Vadistanbul
Spec. MD. Muhsin Doran
Physiotheraphy and Rehabilitation
Liv Hospital Bahçeşehir
Prof. MD. Nazife Berna Tander
Physiotheraphy
Liv Hospital Bahçeşehir
Spec. MD. Gürkan Yılmaz
Rheumatology
Liv Hospital Bahçeşehir
Spec. MD. Roya Soltanalizadeh
Physiotheraphy
Liv Hospital Bahçeşehir
Spec. MD. Sibel Ertürkler
Physiotheraphy
Liv Hospital Topkapı
Spec. MD. Nevzat Koca
Rheumatology
Liv Hospital Topkapı
Spec. MD. Orge Fatoş Demirtaş
Physiotheraphy and Rehabilitation
Liv Hospital Topkapı
Spec. MD. Turgay Demiray
Physiotheraphy and Rehabilitation
Liv Hospital Ankara
Assoc. Prof. MD. Ali Erhan Özdemirel
Rheumatology (Physical Therapy)
Liv Hospital Ankara
Prof. MD. Haşim Çakırbay
Physiotheraphy and Rehabilitation
Liv Hospital Ankara
Spec. MD. Beril Özturan
Physiotheraphy and Rehabilitation
Liv Hospital Gaziantep
Spec. MD. Kasım Osmanoğlu
Physiotheraphy
Liv Hospital Gaziantep
Spec. MD. Başak Öğüt Perktaş
Physiotheraphy
Liv Hospital Gaziantep
Spec. MD. Hasan Kılıç
Rheumatology
Liv Hospital Samsun
Prof. MD. Mehmet Sayarlıoğlu
Rheumatology
Liv Bona Dea Hospital Bakü
MD. ŞAİQ MAHMUDOV
Physiotheraphy
Liv Bona Dea Hospital Bakü
Spec. MD. VEFA QULİYEVA
Pediatric Rheumatology
Liv Bona Dea Hospital Bakü
Spec. MD. Nümuna Aliyeva
Rheumatology
Liv Bona Dea Hospital Bakü
Spec. MD. ZÖHRE HAŞIMOVA
Physiotheraphy
Spec. MD. Şaig Mahmudov
Physiotheraphy and Rehabilitation
Liv Hospital Ulus + Liv Hospital Bahçeşehir
Prof. MD. Şenol Kobak
Rheumatology
Send us all your questions or requests, and our expert team will assist you.
Patients with polymyalgia rheumatica often report aching in the neck, shoulders, upper arms, hips, and thighs. The pain is symmetric and may radiate to the upper arms. Morning stiffness is prominent, frequently exceeding 45 minutes, and can interfere with daily activities. Systemic features such as low‑grade fever, fatigue, and weight loss may also be present. Symptoms typically develop rapidly over a few weeks, distinguishing PMR from slower‑onset rheumatic diseases.
The erythrocyte sedimentation rate (ESR) is often markedly elevated, usually above 40 mm/h, while C‑reactive protein (CRP) rises in parallel, reflecting acute‑phase inflammation. A complete blood count may reveal mild anemia of chronic disease, and liver enzymes can be mildly raised. Although these tests are not disease‑specific, the pattern of high ESR/CRP together with clinical findings strongly supports PMR. Additional serologies such as rheumatoid factor or anti‑CCP are ordered only to exclude other conditions.
While imaging is not mandatory for PMR, it becomes valuable when the clinical picture is unclear. Ultrasound can identify subdeltoid and trochanteric bursitis, as well as tenosynovitis. MRI provides high‑resolution visualization of peri‑articular inflammation and helps differentiate PMR from early rheumatoid arthritis. FDG‑PET/CT assesses whole‑body inflammatory activity and is especially useful if giant cell arteritis is suspected, showing increased uptake in large joints and the aorta. Imaging findings, when combined with clinical criteria, reinforce the diagnosis.
Rheumatoid arthritis presents with joint swelling, erosive changes on imaging, and often positive rheumatoid factor or anti‑CCP antibodies, whereas PMR lacks swelling and responds quickly to low‑dose steroids. Fibromyalgia features widespread pain, tender points, normal inflammatory markers, and chronic symptom duration without the acute inflammatory profile seen in PMR. Additional distinguishing features include the pattern of pain (shoulder/hip girdles in PMR) and the presence of systemic symptoms such as low‑grade fever in PMR.
Initial therapy typically begins with 10–20 mg of prednisone daily. After 2 weeks, if symptoms improve and ESR/CRP drop, the dose is reduced by 2.5–5 mg every 2–4 weeks. Tapering continues until the lowest effective dose is reached, often 2.5–5 mg daily, then further reduced to discontinuation over 6–12 months, depending on relapse risk. Relapses may require temporary dose increases or addition of steroid‑sparing agents like methotrexate. Close monitoring ensures the minimal effective dose while minimizing adverse effects.
BlogPolymyalgia RheumaticaApr 28, 2026Swelling at the temples can signal tension headaches, migraines, or temporal arteritis. Learn causes and fi...
BlogPolymyalgia RheumaticaApr 28, 2026Learn about polymyalgia rheumatica symptoms causing muscle pain and stiffness in shoulders, hips, and neck,...
BlogPolymyalgia RheumaticaFeb 19, 2026Uncover the mystery behind polymyalgia rheumatica (PMR) - a chronic inflammatory condition that primarily i...
BlogPolymyalgia RheumaticaApr 28, 2026Discover how prednisolone for temporal arteritis suppresses inflammation and protects vision when started p...
BlogPolymyalgia RheumaticaApr 28, 2026We explain polymyalgia rheumatica diagnosis through lab tests including ESR and CRP, helping you understand...
BlogPolymyalgia RheumaticaApr 28, 2026Discover the gca medical abbreviation and how Giant Cell Arteritis affects arteries and vision, with key sy...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 26 75